Seroprevalence of Immunoglobulin M and G antibodies to severe acute respiratory syndrome coronavirus 2 infection in Iwo, Nigeria
Résumé
BACKGROUND: In many countries, the preliminary stage of the COVID-19 pandemic has reached its climax and serological studies are extremely important in managing public health responses to the COVID-19 pandemic caused by SARS-CoV-2. The Nucleocapsid protein, a highly immunogenic protein, found only in infected individuals is important in SARS-CoV-2 infection. This study was therefore designed to determine the seroprevalence of SARS-CoV-2 IgM and IgG antibodies to nucleocapsid proteins in Iwo, Nigeria, thereby providing information on the spread of the infection. METHODS: Five millilitres of blood were collected from 360 individuals visiting four selected hospitals in Iwo, Nigeria. Socio-demographic and clinical data of the participants were obtained through a structured questionnaire. SARS-CoV-2 IgM and IgG antibodies against the nucleocapsid protein were detected from plasma samples using commercially available Enzyme-linked Immunoassay kits (Monobind Inc, USA) according to the manufacturer's instructions. Statistical analyses were performed using SPSS software version 21 at P < 0.05 for statistical significance. RESULTS: Out of the tested samples, 37 and 165 were positive for IgM and IgG antibodies giving a prevalence of 10.3% [95% CI: 7.5% - 13.6%] and 45.8% [95% CI: 40.8% - 50.8%], respectively. In total, 184 samples tested positive for SARS-CoV-2 antibodies giving an overall prevalence of 51.1% [95% CI: 45.8% - 56.1%]. Infection was associated with age; older population (35-90 years), fever, cough and muscle pain (p < 0.05). SARS-CoV-2 IgM and IgG antibodies were detected among 11.8% and 42.6% of COVID-19 vaccine recipients, respectively. CONCLUSIONS: High seroprevalence of SARS-CoV-2 antibodies to nucleocapsid proteins were detected among the study population. In particular, is detecting IgM antibodies among those who have received COVID-19 vaccines. This reveals a high level of recent and past exposure to SARS-CoV-2 virus infection and continuous spread within the community.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 29/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →